The potential economic value of screening hospital admissions for Clostridium difficile

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 31, Issue 11, 2012, Pages 3163-3171

  Bartsch, S M ^a,b   Curry, S R ^c   Harrison, L H ^a   Lee, B Y ^a,b  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BACTERIAL COLONIZATION; CHILD; CLOSTRIDIUM DIFFICILE; CONTROLLED STUDY; COST CONTROL; COST EFFECTIVENESS ANALYSIS; HEALTH CARE COST; HEALTH ECONOMICS; HOSPITAL ADMISSION; HUMAN; INFANT; INFECTION RISK; NONHUMAN; PRESCHOOL CHILD; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; SCHOOL CHILD; SCREENING TEST; SENSITIVITY ANALYSIS; SIMULATION; SOCIAL ISOLATION; SOCIOECONOMICS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARRIER STATE; CHILD; CHILD, PRESCHOOL; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; COSTS AND COST ANALYSIS; DIAGNOSTIC TESTS, ROUTINE; FEMALE; HOSPITALS; HUMANS; INFANT; MALE; MASS SCREENING; MIDDLE AGED; MODELS, THEORETICAL; YOUNG ADULT;

EID: 84867987047     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-012-1681-z     Document Type: Article

References (61)

1. Heinlen L, Ballard JD (2010) Clostridium difficile infection. American Journal of the Medical Sciences 340(3):247-252
2. Missaghi B, Valentia AJ, Owens RCJ (2008) Clostridium difficile infection: a critical overview. Current Infectious Disease Reports 10:165-173
3. McGlone SM, Bailey RR, Zimmer SM, Popovich MJ, Tian Y, Ufberg PJ, Muder RR, Lee BY (2012) The economic burden of Clostridium difficile. Clin Microbiol Infect. 18(3):282-289
4. Dubberke ER, Wertheimer AI (2009) Review of current literature on the economic burden of Clostridium difficile infection. Infect Control Hosp Epidemiol 30(1):57-66
5. Kelly CP, LaMont JT (2008) Clostridium difficilemore difficult than ever. N Engl J Med 359:1932-1940
6. McFarland LV, Mulligan ME, Kowk RYY, Stamm WE (1989) Nosocomial acquisition of Clostridium difficile infection. N Engl J Med 320(4):204-210
7. Riggs MM, Sethi AK, Zabarsky TF, Ec E, Jump RLP, Donskey CJ (2007) Asymptomatic carriers are a potential source for transmission of epidemic and nonepidemic Clostridium difficile strains among long-term care facility residents. Clin Infect Dis 45:992-998
8. Clabots CR, Johnson S, Olson MM, Peterson LR, Gerding DN (1992) Acquisition of Clostridium difficile by hospitalized patients: evidence for colonized new admissions as a source of infection. J Infect Dis 166:561-567
9. Cohen SH, Gerding DN, Johnson S, Kelly CP, Loo VG, McDonald LC, Pepin J, Wilcox MH (2010) Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infections Diseases Society of America (IDSA). Infect Control Hosp Epidemiol 31(5):431-455
10. Sloan LM, Duresko BJ, Gustafson DR, Rosenblatt JE (2008) Comparison of real-time PCR for detection of the tcdC gene with four toxin immunoassays and culture in diagnosis of Clostridium difficile infection. J Clin Microbiol 46(6):1996-2001
11. Stamper PD, Alcabasa R, Aird D, Babiker W, Wehrlin J, Ikpeama I, Carroll KC (2009) Comparison of a commercial real-time PCR assay for tcdB detection to a cell culture cytotoxicity assay and toxigenic culture for direct detection of toxin-producing Clostridium difficile in clinical samples. J Clin Microbiol 47(2):373
12. Stamper PD, Babiker W, Alcabasa R, Aird D, Wehrlin J, Ikpeama I, Gluck L, Carroll KC (2009) Evaluation of a new commercial TaqMan PCR assay for direct detection of the Clostridium difficile toxin B gene in clinical stool samples. J Clin Microbiol 47(12):3846
13. Curry SR, Gee JL, Hamilton TM, Henderson TK, Brown NT, Marsh JW, Shutt KA, Brooks MM, Pasculle AW, Muto CA, Harrison LH (2011) Peri-rectal swab surveillance for Clostridium difficile using selective broth pre-amplification and real-time PCR detection of tcdB. J Clin Microbiol 49(11):3788-3793
14. United States Department of Health & Human Services (2009) HCUP facts and figures: statistics on hospital-based care in the United States, 2009. AHRQ: Agency for Healthcare Research and Quality. http://www.hcup-us.ahrq.gov/ reports.jsp. Accessed 2 February 2012
15. Leffler DA, LaMont JT (2009) Treatment of Clostridium difficile-associated disease. Gastroenterology 136:1899-1912
16. Ramsey S, Veenstra D, Clarke L, Gandhi S, Hirsch M, Penson D (2005) Is combined androgen blockade with bicalutamide cost-effective compared with combined androgen blockade with flutamide? Urology 66(4):835-839
17. Penson D, Ramsey S, Veenstra D, Clarke L, Gandhi S, Hirsch M (2005) The cost-effectiveness of combined androgen blockade with bicalutamide and luteinizing hormone releasing agonist in men with metastatic prostate cancer. J Urol 174(2):547-552
18. Hayes JL, Hansen P (2007) Is laparoscopic colectomy for cancer cost-effective relative to open colectomy? ANZ J Surg 77(9):782-786
19. Neumann PJ, Sandberg EA, Bell CM, Stone PW, Chapman RH (2000) Are pharmaceuticals cost-effective? A review of the evidence. Heal Aff 19(2):92-109
20. Graves N (2004) Economics and preventing hospital-acquired infection. Emerg Infect Dis 10(4):561-566
21. Marciniak C, Chen D, Stein AC, Semik PE (2006) Prevalence of Clostridium difficile colonization at admission to rehabilitation. Arch Phys Med Rehabil 87(8):1086-1890
22. Loo VG, Bourgault A-M, Poirier L, Lamothe F, Michaud S, Turgeon N, Toye B, Beaudoin A, Frost EH, Gilca R, Brassard P, Dendukuri N, Beliveau C, Oughton M, Brukner I, Dascal A (2011) Host and pathogen factors for Clostridium difficile infection and colonization. N Engl J Med 365:1693-1703
23. Shim JK, Johnson S, Samore MH, Bliss DZ, Gerding DN (1998) Primary symptomless colonisation by Clostridium difficile and decreased risk of subsequent diarrhoea. Lancet 351:633-636
24. Kyne L, Hamel MB, Polavaram R, Kelly CP (2002) Health care costs and mortality associated with nosocomial diarrhea due to Clostridium difficile. Clin Infect Dis 34:346-353
25. Pepin J, Valiquette L, Cossette B (2005) Mortality attributable to nosocomial Clostridium difficile-associated disease during an epidemic caused by a hypervirulent strain in Quebec. CMAJ 173(9):1037
26. Song X, Bartlett JG, Speck K, Naegeli A, Carroll KC, Perl TM (2008) Rising economic impact of Clostridium difficileassociated disease in adult hopsitalized patient population. Infect Control Hosp Epidemiol 29(9):823-828
27. Forster AJ, Taljarrd M, Oake N, Wilson K, Roth V, van Walraven C (2012) The effect of hospital-acquired infection with Clostridium difficile on length of stay in hospital. CMAJ 184(1):37-42
28. Pakyz A, Carroll NV, Harpe SE, Oinonen M, Polk RE (2011) Economic impact of Clostridium difficile infection in a mulithospital cohort of academic health centers. Pharmacotherapy 31(6):546-551
29. Vonberg R-P, Reichardt C, Behnke M, Schwab F, Zindler S, Gastmeier P (2008) Costs of nosocomial Clostridium difficile-associated diarrhoea. J Hosp Infect 70(1):15-20
30. Ghantoji SS, Sail K, Lairson D, DuPont HL, Garey KW (2010) Economic healthcare costs of Clostridium difficile infection: a systematic review. J Hosp Infect 74:309-318
31. McGlone SM, Bailey RR, Zimmer SM, Popovich MJ, Tian Y, Ufberg PJ, Muder RR, Lee BY (2012) The economic burden of Clostridium difficile. Clin Microbiol Infect 18(3):282-289
32. Lanzas C, Dubberke ER, Lu Z, Reske KA, Grohn YT (2011) Epidemiological model for Clostridium difficile transmission in healthcare settings. Infect Control Hosp Epidemiol 32(6):553-561
33. Lee BY, Bailey RR, Smith KJ, Muder RR, Strotmeyer ES, Lewis GJ, Ufberg PJ, Song Y, Harrison LH (2010) Universal methicillin-resistant Staphylococcus aureus (MRSA) surveillance for adults at hospital admission: an economic model and analysis. Infect Control Hosp Epidemiol 31(6):598-606
34. Lee BY, McGlone SM, Doi Y, Bailey RR, Harrison LH (2011) Economic value of Acinetobacter baumannii screening in the intensive care unit (ICU). Clin Microbiol Infect 17(11):1691-1697
35. Lee BY, Song Y, McGlone SM, Bailey RR, Feura J, Tai JHY, Lewis GJ, Wiringa AE, Smith KJ, Muder RR, Harrison LH, Piraino B (2011) The economic value of screening haemodialysis patients for methicillin-resistant Staphylococcus aureus in the USA. Clin Microbiol Infect 17(11):1717-1726
36. Lee BY, Tsui B, Bailey RR, Smith KJ, Muder RR, Lewis GJ, Harrison LH (2009) Should vascular surgery patients be screened preoperatively for methicillin-resistant Staphylococcus aureus? Infect Control Hosp Epidemiol 30(12):1158-1165
37. Lee BY, Wiringa AE, Bailey RR, Goyal V, Lewis GJ, Tsui B, Smith KJ, Muder RR (2010) Screening cardiac surgery patients for MRSA: an economic computer model. Am J Manag Care 16(7):e163-e173
38. Lee BY, Wiringa AE, Bailey RR, Goyal V, Tsui B, Lewis GJ, Muder RR, Harrison LH (2010) The economic effect of screening orthopedic surgery patients preoperatively for methicillin-resistant Staphylococcus aureus. Infect Control Hosp Epidemiol 31(11):1130-1138
39. Kato H, Kita H, Karasawa T, Maegawa T, Koino Y, Takakuwa H, Saikai T, Kobayashi K, Yamagishi T, Nakamura S (2001) Colonisation and transmission of Clostridium difficile in healthy individuals examined by PCR ribotyping and pulsed-field gel electrophoresis. J Med Microbiol 50(8):720-727
40. Nakamura S, Mikawa M, Nakashio S, Takabatake M, Okado I, Yamakawa K, Serikawa T, Okumura S, Nishida S (1981) Isolation of Clostridium difficile from the feces and the antibody in sera of young and elderly adults. Microbiol Immunol 25(4):345-351
41. Ozaki E, Kato H, Kita H, Karasawa T, Maegawa T, Koino Y, Matsumoto K, Takada T, Nomoto K, Tanaka R, Nakamura S (2004) Clostridium difficile colonization in healthy adults: transient colonization and correlation with enterococcal colonization. J Med Microbiol 53(Pt 2):167-172
42. Viscidi R, Willey S, Bartlett JG (1981) Isolation rates and toxigenic potential of Clostridium difficile isolates from various patient populations. Gastroenterology 81(1):5-9
43. Lee BY (2008) Digital decision making: computer models and antibiotic prescribing in the twenty-first century. Clin Infect Dis 46(8):1139-1141
44. Abad C, Fearday A, Safdar N (2010) Adverse events of isolation in hospitalised patients: a systematic review. J Hosp Infect 76:97-102
45. Puzniak LA, Gillespie KN, Leet T, Kollef M, Mundy LM (2004) A cost-benefit analysis of gown use in controlling vancomycin-resistant Enterococcus transmission: is it worth the price? Infect Control Hosp Epidemiol 25:418-424
46. Bureau of Labor Statistics (2010) Occupational employment statistics: May 2009 national occupational employment and wage estimates, United States. U.S. Bureau of Labor Statistics Division of Occupational Employment Statistics. http://stat.bls.gov/oes/2008/may/oes-nat.htm#b00-0000. Accessed November 2011
47. American Medical Association (2011) CPT code/relative value search. https://ocm.ama-assn.org/OCM/CPTRelativeValueSearch.do. Accessed April 27 2011
48. PDR (2010) Red Book Pharmacy's fundamental reference. Thompson Reuters (Healthcare), Inc., Montvale, NJ
49. Gold MR, Franks P, McCoy KI, Fryback DG (1998) Toward consistency in cost-utility analyses: using national measures to create condition-specific values. Medical Care 36(6):778-792
50. Fujitani S, George WL, Murthy AR (2011) Comparison of clinical severity score indices for Clostridium difficile infection. Infect Control Hosp Epidemiol 32(3):220-228
51. Henrich TJ, Krakower D, Bitton A, Yokoe DS (2009) Clinical risk factors for severe Clostridium difficile-associated disease. Emerg Infect Dis 15(13):415-422
52. Barbut F, Gariazzo B, Bonne L, Lalande V, Burghoffer B, Luiuz R, Petit H-C (2007) Clinical features of Clostridium difficile-associated infections and molecular characterization of strains: results of a retrospective study, 2000-2004. Infect Control Hosp Epidemiol 28(2):131-139
53. Ricciardi R, Rothenberger DA, Madoff RD, Baxter NN (2007) Increasing prevalence and severity of Clostridium difficile colitis in hospitalized patients in the United States. Arch Surg 142(7):624-631
54. Jaber MR, Olfsson S, Fung WL, Reeves ME (2008) Clinical review of the management of fulminant Clostridium difficile infection. Am J Gastroenterol 103:3195-3203
55. Pepin J, Vo TT, Boutros M, Marcotte E, Dial S, Bube S, Vasilevsky C-A, McFadden N, Patino C, Labbe A-C (2009) Risk factors for mortality following emergency colectomy for fulminant Clostridium difficile infection. Dis Colon Rectum 52(3):400-405
56. Lamontagne F, Labbe A-C, Haeck O, Lesur O, Lalancette M, Patino C, Leblanc M, Laverdiere M, Pepin J (2007) Impact of emergency colectomy on survival of patients with fulminant Clostridium difficile colitis during an epidemic caused by a hypervirulent strain. Ann Surg 245(2):267-272
57. Barbut F, Richard A, Hamadi K, Chomette V, Burghoffer B, Petit J-C (2000) Epidemiology of recurrences or reinfections of Clostridium difficile-associated diarrhea. J Clin Microbiol 38(6):2386-2388
58. Fekety R, McFarland LV, Surawicz CM, Greenberg RN, Elmer GW, Mulligan ME (1997) Recurrent Clostridium difficile diarrhea: characteristics of and risk factors for patients enrolled in a prospective, randomized, double-blinded trial. Clin Infect Dis 24(3):324-333
59. Bauer MP, Kuijper EJ, van Dissel JT (2009) European Society of Clinical Microbiology and Infectious Diseases (ESCMID): treatment guidance document for Clostridium difficile infection (CDI). Clin Microbiol Infect 15:1067-1079
60. McFarland LV, Elmer GW, Surawicz CM (2002) Breaking the cycle: treatment strategies for 163 cases of recurrent Clostridium difficile disease. Am J Gastroenterol 97(7):1769-1775. doi: 10.1111/j.1572-0241.2002.05839.x
61. Jernigan JA, Clemence MA, Stott GA, Titus MG, Alexander CH, Palumbo CM, Farr BM (1995) Control of methicillin-resistant Staphylococcus aureus at a university hospital: one decade later. Infect Control Hosp Epidemiol 16(12):686-696